The effect of 7-Keto Naturalean™ on weight loss:: A randomized, double-blind, placebo-controlled trial

被引:12
作者
Zenk, JL
Helmer, TR
Kassen, LJ
Kuskowski, MA
机构
[1] Minnesota Appl Res Ctr, Chanhassen, MN 55317 USA
[2] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA
来源
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 2002年 / 63卷 / 04期
关键词
weight loss; 7-oxo-DHEA; dehydroepiandrosterone; obesity;
D O I
10.1016/S0011-393X(02)80031-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: A natural metabolite of dehydroepiandrosterone (DHEA), 3-acetyl-7-oxo-dehydroepiandrosterone (7-oxo-DHEA), has been shown to be effective in enhancing weight loss when combined with a diet and exercise program. Objective: This study assessed the effects of a formula containing 7-oxo-DHEA, L-tyrosine, asparagus root extract, choline bitartrate, inositol, copper gluconate, manganese, and potassium iodide (7-Keto Naturalean(TM)) on weight loss, body composition, and basal metabolic rate (BMR) in overweight patients following a weight-reduction diet and exercise regimen. Methods: In this prospective, randomized, double-blind, placebo-controlled trial, healthy, overweight adults were given 7-Keto Naturalean (200 mg/d) or a placebo of maltodextrin and followed a calorie-restricted diet (105 kJ/kg) and an exercise program for 8 weeks. Body weight, body composition (by bioelectric impedance), and BMR (by indirect calorimetry) were measured at baseline, week 4, and week 8. A thyroid panel was done at baseline and week 8. Results: Of 35 healthy, overweight adults enrolled, 33 completed the study (12 men, 21 women; age, 40-69 years; body mass index [BMI], 27.0-42.7 kg/m(2)). Patients taking 7-Keto Naturalean lost significantly more weight after 8 weeks than those taking placebo (mean +/- SD loss, 2.15 +/- 2.38 kg and 0.72 +/- 2.12 kg, respectively) (P = 0.038). The change in BMI in the 7-Keto Naturalean-treated group was significant compared with the change in the placebo group (mean +/- SD decrease, 0.71 +/- 0.79 kg/m(2) and 0.01 +/- 1.05 kg/m(2), respectively) (P = 0.036). There were no other statistically significant differences in any of the other measured variables. 7-Keto Naturalean was well tolerated, and there were no significant adverse events. Conclusion: In this select population, 7-Keto Naturalean combined with a reduced-calorie diet and an exercise program resulted in a significant weight loss compared with diet and exercise alone.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 50 条
[31]   The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: A double-blind, randomized, placebo-controlled trial [J].
Tek, Cenk ;
Palmese, Laura B. ;
Krystal, Andrew D. ;
Srihari, Vinod H. ;
DeGeorge, Pamela C. ;
Reutenauer, Erin L. ;
Guloksuz, Sinan .
SCHIZOPHRENIA RESEARCH, 2014, 160 (1-3) :180-185
[32]   A randomized, double-blind, placebo-controlled study of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy overweight adults [J].
Kalman, DS ;
Colker, CM ;
Swain, MA ;
Torina, GC ;
Shi, QH .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (07) :435-442
[33]   Efficacy and safety of Amomum villosum extracts in obese adults: A randomized, double-blind, placebo-controlled trial [J].
Lee, Jung-Han ;
Kim, Ha-Rim ;
Antonisamy, Paulrayer ;
Kim, Ye-Seul ;
Ryu, Do-Gon ;
Lee, Guemsan ;
Kwon, Kang-Beom .
JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2023, 35 (03)
[34]   Propolis as an adjunctive therapy for treatment of uncomplicated cystitis in women: A randomized double-blind placebo-controlled trial [J].
Shekari, Mahdi ;
Hadi, Amir ;
Daabo, Hamid Mahmood Abdullah ;
Allahyari, Zahra Haj ;
Hjazi, Ahmed ;
Rafie, Nahid ;
Heidari, Mohammad .
PHYTOTHERAPY RESEARCH, 2024, 38 (02) :520-526
[35]   Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial [J].
Kashani, Ladan ;
Shams, Nazila ;
Moazen-Zadeh, Ehsan ;
Karkhaneh-Yousefi, Mohammad-Ali ;
Sadighi, Gita ;
Khodaie-Ardakani, Mohammad-Reza ;
Rezaei, Farzin ;
Rahiminejad, Fatemeh ;
Akhondzadeh, Shahin .
JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 94 :70-77
[36]   Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study [J].
Finer, N ;
Bloom, SR ;
Frost, GS ;
Banks, LM ;
Griffiths, J .
DIABETES OBESITY & METABOLISM, 2000, 2 (02) :105-112
[37]   Effect of garlic extract on weight loss and gut microbiota composition in obese women: A double-blind randomized controlled trial [J].
Ettehad-Marvasti, Fateme ;
Ejtahed, Hanieh-Sadat ;
Siadat, Seyed-Davar ;
Soroush, Ahmad-Reza ;
Hoseini-Tavassol, Zahra ;
Hasani-Ranjbar, Shirin ;
Larijani, Bagher .
FRONTIERS IN NUTRITION, 2022, 9
[38]   A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Naltrexone to Counteract Antipsychotic-Associated Weight Gain Proof of Concept [J].
Tek, Cenk ;
Ratliff, Joseph ;
Reutenauer, Erin ;
Ganguli, Rohan ;
O'Malley, Stephanie S. .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (05) :608-612
[39]   Zonisamide for Bipolar Depression: A Randomized, Double Blind, Placebo-Controlled, Adjunctive Trial [J].
Dauphinais, Deborah ;
Knable, Michael ;
Rosenthal, Joshua ;
Polanski, Mark ;
Rosenthal, Norman .
PSYCHOPHARMACOLOGY BULLETIN, 2011, 44 (02) :73-84
[40]   Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by β-adrenergic blocking agents:: a placebo-controlled, double-blind, randomised trial [J].
Sramek, JJ ;
Leibowitz, MT ;
Weinstein, SP ;
Rowe, ED ;
Mendel, CM ;
Levy, B ;
McMahon, FG ;
Mullican, WS ;
Toth, PD ;
Cutler, NR .
JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (01) :13-19